These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 10213023

  • 21. Treatment of gastroesophageal reflux disease.
    Pettit M.
    Pharm World Sci; 2005 Dec; 27(6):432-5. PubMed ID: 16341949
    [Abstract] [Full Text] [Related]

  • 22. The impact of over-the-counter availability of nasal sprays on sales, prescribing, and physician visits.
    Lundberg L, Isacson D.
    Scand J Prim Health Care; 1999 Mar; 17(1):41-5. PubMed ID: 10229992
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Influenza Antiviral Expenditures and Outpatient Prescriptions in the United States, 2003-2012.
    Suda KJ, Hunkler RJ, Matusiak LM, Schumock GT.
    Pharmacotherapy; 2015 Nov; 35(11):991-7. PubMed ID: 26598091
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Co-prescription of gastroprotective agents in patients taking non-selective NSAIDs or COX-2 selective inhibitors: analysis of prescriptions.
    Pasina L, Nobili A, Tettamanti M, Riva E, Lucca U, Piccinelli R, Defendi L, Perego L, Lucifora S, Bulla C.
    Int J Clin Pharmacol Ther; 2010 Nov; 48(11):735-43. PubMed ID: 20979932
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care.
    Martin RM, Lim AG, Kerry SM, Hilton SR.
    Aliment Pharmacol Ther; 1998 Aug; 12(8):797-805. PubMed ID: 9726394
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy.
    Sullivan PW, Nair KV, Patel BV.
    Am J Manag Care; 2005 Jun; 11(6):374-82. PubMed ID: 15974556
    [Abstract] [Full Text] [Related]

  • 38. Opioid pain medication prescriptions obtained through emergency medical visits in the Veterans Health Administration.
    Grasso MA, Dezman ZDW, Grasso CT, Jerrard DA.
    J Opioid Manag; 2017 Jun; 13(2):77-84. PubMed ID: 28829522
    [Abstract] [Full Text] [Related]

  • 39. Impact of interventions designed to increase market share and prescribing of fexofenadine at HMOs.
    Benedetto SR, Sloan AS, Duncan BS.
    Am J Health Syst Pharm; 2000 Oct 01; 57(19):1778-85. PubMed ID: 11030030
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.